Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of AEB071 in preventing acute rejections
after kidney transplantation, when combined with tacrolimus for the first 3 months and with
myfortic thereafter.